All analyses were performed with the SAS program, edition 9.1 . Outcomes Patients A total of 8392 patients were assessed for eligibility, of whom 8323 were randomly assigned to a report group . A complete of 16 patients were subsequently excluded either because that they had been given an erroneous randomization number or because they did not receive the study medication and had zero follow-up data . The final intention-to-treat population included 8307 patients, of whom 2071 were enrolled in China , 4050 in India , 383 in Korea , 292 in Malaysia , 396 in Mexico , 585 in the Philippines , and 530 in Tunisia .Finally, protection analyses within histologic subgroups were in keeping with the overall human population, with nab-Computer versus sb-PC being associated with a lesser frequency of quality 3/4 sensory neuropathy and arthralgia, and a higher frequency of anemia and thrombocytopenia. All privileges reserved. Neither of these parties endorse or suggest any commercial products, services, or equipment.. Manesh R. Patel, M.D., Eric D. Peterson, M.D., M.P.H., David Dai, M.S., J. Matthew Brennan, M.D., Rita F. Redberg, M.D., H. Vernon Anderson, M.D., Ralph G. Brindis, M.D., and Pamela S.